ResMed Inc. (NYSE: RMD) stock closed at 158.85 per share at the end of the most recent trading day (a 2.04% change compared to the prior day closing price) with a volume of 1.73M shares and market capitalization of 23.37B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 7970 people. ResMed Inc. CEO is Michael J. Farrell.

The one-year performance of ResMed Inc. stock is -30.25%, while year-to-date (YTD) performance is -23.68%. RMD stock has a five-year performance of 42.1%. Its 52-week range is between 132.24 and 243.52, which gives RMD stock a 52-week price range ratio of 23.91%

ResMed Inc. currently has a PE ratio of 39.00, a price-to-book (PB) ratio of 8.91, a price-to-sale (PS) ratio of 11.25, a price to cashflow ratio of 66.60, a PEG ratio of 4.88, a ROA of 16.80%, a ROC of 18.86% and a ROE of 25.73%. The company’s profit margin is 21.47%, its EBITDA margin is 33.20%, and its revenue ttm is $2.73 Billion , which makes it $18.63 revenue per share.

Of the last four earnings reports from ResMed Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.63 for the next earnings report. ResMed Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for ResMed Inc. is Moderate Buy (1.79), with a target price of $261.11, which is +64.38% compared to the current price. The earnings rating for ResMed Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ResMed Inc. has a dividend yield of 0.84% with a dividend per share of $1.76 and a payout ratio of 48.00%.

ResMed Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.75, ATR14 : 4.55, CCI20 : 194.70, Chaikin Money Flow : 0.02, MACD : 2.60, Money Flow Index : 55.32, ROC : 10.76, RSI : 64.39, STOCH (14,3) : 77.46, STOCH RSI : 1.00, UO : 55.01, Williams %R : -22.54), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ResMed Inc. in the last 12-months were: Brett A. Sandercock (Sold 14 000 shares of value $3 012 196 ), Brett Sandercock (Sold 30 000 shares of value $6 738 579 ), David B. Pendarvis (Sold 10 500 shares of value $2 335 095 ), Kaushik Ghoshal (Sold 4 500 shares of value $1 019 650 ), Michael J. Farrell (Sold 0 shares of value $-1 638 940 ), Michael J. Farrell (Sold 28 375 shares of value $6 163 114 ), Rider Michael J (Sold 25 shares of value $5 603 ), Robert Andrew Douglas (Sold 6 000 shares of value $1 297 080 )